EpilepsyGTx’s Post

Finally effective screening for esophageal cancer from Lucid Medical Diagnostics. This in-office non-invasive test can detect pre-cancerous cells and alert you to esophageal cancer early when it us treatable. Having done esophagectomies, they are a morbid operation and only 20% of patients have long term survival. Early detection is the key. We must do screening just like in breast, colon, lung, skin and other cancers. #cancer #screening #esoguard

At the annual European Society for Medical Oncology (ESMO) congress in Barcelona, Spain, Illumina brought together oncologists, patient advisory groups, clinicians, and researchers to discuss the growing evidence on the benefits of comprehensive genomic profiling (CGP) using liquid biopsy, and how it can help to inform therapy decisions and improve patient care. This revolutionary technique uses a blood test to detect circulating tumor #DNA, which is then sequenced to assess multiple biomarkers in numerous tumor types using a single next-generation sequencing assay. This process is less invasive for patients, requiring a one-time test rather than multiple biopsies, which can add to the patient’s discomfort and prolong the wait for a diagnosis. #illuminaproud #genomics #makeadifference

#Antibodydrugconjugates payloads: then, now and next 👇 @DrugTargetRev reflect on how #ADCs and their payloads have changed, take a look at some of the less common payloads being explored, and investigate the potential of dual-drug #ADCs. Read more below 👇 https://lnkd.in/eF_87s4g

Happy Monday! Wonder the ADC’s past, present, and future? This article is short enough but informative to grasp the basics. #antibodydrugconjugates #drugsafety #drugdevelopment

Dr. He and his team have developed new methods to map the targets of the SNORD genes in PWS. FPWR has funded him to use these methods on mouse models and human cell lines of PWS to better understand the function of these critical PWS genes. https://fpwr.us/3QrTMch

Day 3 at #PepTalk2024. Today's topic is about how our MHC Monomers & Tetramers can help in facilitate tumor research and development. Our products come in several formats and exhibit high stability. If you are having trouble finding our poster #B20, don't worry - just come by our booth #217 and we'll give you all the information you need. We are excited to connect with all of you and exchange ideas! #KACTUS #CHIPepTalk #Antibodies #AntibodyTherepeutics #ProteinEngineering #AntibodyDiscovery #AntibodyCharacterization

Register today for #IndicaLabs' first webinar of the new year, in collaboration with #ACD, that will be presented by Dr. Julia Jones of CRUK-CI. Don't miss her 1 Feb presentation where you can learn all about #RNAscope HiPlex and #HALOimageanalysis! #digitalpathology

#ESMO24 (Day 1 and 2) 📢 If you are interested in the #Claudin (#CLDN) space, please check out my #CLDN18.2 and #CLDN1 selected presentations. 📢Huge competition in the CLDN18.2 space, but ORR data are consistent across ADC assets (check out also my #ASCO24 post) #CLDN1 #Biology High CLDN1 expression is associated with immune exclusion, particularly in A-subtype NPC with downregulation of immune pathways and reduced abundances of active immune subset (Eugenia LL Yeo) #CLDN18.2 #ADC -#XNW27011 (TOPOli payload). 64% ORR in 11 CLDN18.2+ pts with solid tumors (GC/GEJC, ovarian, and PDAC). - #RC118 (MMAE payload). 54.5% ORR in 11 CLDN18.2+ (GC/GEJC) dosed at 2.0mg/Kg Q2W

Together with HALO Macrodissection Solutions, HALO AP® 2.3 adds expanded support for #macrodissection workflows. Users can easily annotate slides for downstream analysis using AI-generated tumor heatmaps. #DigitalPathology #HALOap #CEIVD #IndicaLabs

Over the last one year and some change, we have been vocal about the growing cancer burden in India and how we are working tirelessly to create access to quality precision treatment. This time around watch Manikandan Bala interact with India's prime business TV channel ETNow where he addresses: 1.      What we at Elekta have done in India to tackle the growing concern. 2.      How the technology landscape in Radiation Oncology is evolving. 3.      Specialized treatment with Gamma Knife® for all intracranial care. 4.      Digitization and software the heart of this care revolution. 5.      The cost of addressing the disease and the value we bring as Elekta Habib Nehmé Gustaf Salford Emma Jogic Mattias Thorsson https://lnkd.in/gKiR-Njj?